The Chinese government has targeted high-technology industries as a strategic growth priority. The investment to strengthen national players has started to pay off and technological innovation is one of the main growth drivers for the country. China´s digital economy now accounts for about 30% of GDP - having more than doubled from 2008. Our rules-based and transparent solution aims to capture these opportunities by selecting the 100 largest technology-driven Chinese companies.
Step-by-step: Solactive China Technology index portfolio construction
In addition to selecting companies from the traditional technology sector and health technology sub-sector, the Solactive China Technology Index also includes companies which derive the majority of their revenues from various innovative, technology-related business activities, including genomics, robotics and automation, cybersecurity, digital entertainment, cloud computing, future cars, blockchain and social media.
Figure: Index methodology overview
The table displays five columns that outline the construction of the Index methodology. They are structured as Sectors & Economies, Exchanges included, Inclusion weights, Top 100 largest stocks and Diversification.
In order to capture most of the available opportunities, the index incorporates onshore, offshore as well as foreign listings in its eligible universe. To keep the index replicable, only A-shares trading through Stock Connect are eligible and are included at 20% of their free-float market capitalization to reflect foreign ownership restrictions. Once the largest 100 stocks are selected, a 10% security capping is applied to individual components to diversify issuer risks.
This content is for professional clients only. It is not to be distributed to or relied upon by Retail Clients under any circumstances.
Views and opinions expressed are presented for informational purposes only and are a reflection of UBS Asset Management’s best judgment at the time a report or other content was compiled. UBS specifically prohibits the redistribution or reproduction of this material in whole or in part without the prior written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect. The information and opinions contained in the content of this webpage have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any errors or omissions. All such information and opinions are subject to change without notice but any obligation to update or alter forward-looking statement as a result of new information, future events, or otherwise is disclaimed. Source for all data/charts, if not stated otherwise: UBS Asset Management.
Any market or investment views expressed are not intended to be investment research. Materials have not been prepared to address requirements designed to promote the independence of investment research and are not subject to any prohibition on dealing ahead of the dissemination of investment research. The information contained in this webpage does not constitute a distribution, nor should it be considered a recommendation to purchase or sell any particular security or fund. The materials and content provided will not constitute investment advice and should not be relied upon as the basis for investment decisions. As individual situations may differ, clients should seek independent professional tax, legal, accounting or other specialist advisors as to the legal and tax implication of investing. Plan fiduciaries should determine whether an investment program is prudent in light of a plan's own circumstances and overall portfolio. A number of the comments in the content of this webpage are considered forward-looking statements. Actual future results, however, may vary materially. Past performance is no guarantee of future results. Potential for profit is accompanied by possibility of loss.
© UBS 2021 The key symbol and UBS are among the registered and unregistered trademarks of UBS.